Topiramate prophylaxis in patients suffering from migraine with aura: Results from a randomized, double-blind, placebo-controlled trial

Advanced Studies in Medicine

Volumn 3, Issue 6 C, 2003, Pages

  Freitag, Frederick G ^a  

^a DIAMOND HEADACHE CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CARBONATE DEHYDRATASE INHIBITOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMATE RECEPTOR; PLACEBO; TOPIRAMATE;

ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERABILITY; EXPERIENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; NEUROTRANSMITTER RELEASE; PROPHYLAXIS; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT INDICATION;

EID: 0037972893     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Storey JR, Caldor CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41(10):968-975.
2. Wheeler SD, Carrazana EJ. Topiramate-treated cluster headache. Neurology. 1999;53(1):234-236.
3. Silberstein SD. Efficacy of topiramate in migraine prophylaxis: a randomized controlled study. Adv Stud Med. 2002;2(21):758-761.
4. Cutter FM. Antiepileptic drugs and how they work in headache. Headache. 2001;4(suppl 1):S3-S10.
5. Ptacok LJ. Channelopothies: ion channel disorders of the muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord. 1997;7:250-255.
6. Alam Z, Coombes N, Waring RH, Williams AC, Steventon GB. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J Neurol Surg. 1998;156:102-106.
7. Conanzi AR, D'Andrea C, Porini F, Zamberlan F, Welch KM. Platelet and plasma levels of glutamate and glutamine in migraine with and without aura. Cephalalgia. 1995;15:132-135.
8. Sank RP, Gardocki JF, Streeter AJ, Maryanoff BE. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanisms of action. Epilepsia. 2000;44(suppl 1):53-59.